Title: Borneo Journal of Pharmacy
ISSN: 2621-4814 (Online)
Accreditation: SINTA 2 until 2025 by the Minister of Research and Technology/National Research and Innovation Agency, Indonesia No: 148/M/KPT/2020.
Subject: Pharmacy and Pharmaceutical Sciences
Frequency: Quarterly (4 issues per year in February, May, August, and November) onward February 2020
Indexed at: EMBASESINTA 2, Dimensions, DOAJ, SHERPA RoMEO, Crossref, Index Copernicus InternationalResearchBib, Google Scholar, GARUDA, and more
DOI: 10.33084/bjop
Archive preservation: Indonesia OneSearch, GARUDA
Publisher: Institute for Research and Community Services Universitas Muhammadiyah Palangkaraya
Editor in Chief: Mohammad Rizki Fadhil Pratama

Borneo Journal of Pharmacy (Borneo J Pharm, ISSN: 2621-4814 (online)) is an international scientific platinum open-access journal managed by the Department of Pharmacy Faculty of Health Science Universitas Muhammadiyah Palangkaraya and published four times a year (in February, May, August, and November) onward February 2020 by Institute for Research and Community Services Universitas Muhammadiyah Palangkaraya. Borneo Journal of Pharmacy accepts scientific articles as original research articles, short communication, reviews, and mini-reviews from anyone without any discrimination, as long as they submit articles that meet scientific principles.

As a distinctive feature, the Borneo Journal of Pharmacy prioritizes research articles conducted on the island of Borneo (consisting of Indonesia, Malaysia, and Brunei Darussalam), as well as those conducted by researchers from institutions on the island of Borneo. In every volume, there are always articles written by authors from the island of Borneo. However, articles from researchers outside the island of Borneo are also welcome.

Borneo Journal of Pharmacy publishes various scientific articles covering Pharmacy and Pharmaceutical Sciences, in the field but not limited to Pharmacology-Toxicology, including pharmacokinetics, pharmacodynamics, pharmacotherapy, and toxicology; Pharmacognosy-Phytochemistry, including pharmacognosy, phytochemistry, ethnobotany, and ethnopharmacology; Pharmaceutical, including biopharmaceuticals, pharmaceutical technology, formulations, and biotechnology; Analytical Pharmacy-Medicinal Chemistry, including pharmaceutical chemistry, chemical analysis, medicinal chemistry, bioinformatics, pharmacy physics, pharmaceutical analysis, and method validation; Microbiology Pharmacy, including the test for antibacterial, antifungal and antiviral activity; Natural Product Development, including testing the pharmacological activity of extracts, fractions, and plant isolates; Clinical-Community Pharmacy, including monitoring usage, side effects, counseling, and evaluation of drug use; Management Pharmacy, including drug management, drug use profiles, pharmaceutical administration, and marketing.

Borneo Journal of Pharmacy provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge. All articles published in the Borneo Journal of Pharmacy are open access and free for access as stated in Budapest Open Access Initiative:

"By 'open access' to this literature, we mean its free availability on the public internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from gaining access to the internet itself. The only constraint on reproduction and distribution, and the only role for copyright in this domain, should be to give authors control over the integrity of their work and the right to be appropriately acknowledged and cited."

Editors accept submissions of a well-prepared manuscript that has not been published in other publications. The manuscript format and requirements are listed on the back cover page. Incoming manuscripts will be evaluated and edited to uniformity of structures, terms, and other writing procedures. All manuscripts will be reviewed by the double-blind method by our selective reviewers.

It was first published in 2018 using the Open Journal System (OJS) 3.1. The Borneo Journal of Pharmacy publishes about 40 articles divided into four issues every year. Authors continue to retain the copyright to the article if the article is published in the Borneo Journal of Pharmacy. They will also retain the publishing rights to the article without any restrictions.


Notification of limitations on publishing review articles and articles using the molecular docking method


Dear prospective authors from the Borneo Journal of Pharmacy,

Due to the large number of submissions we receive, while our review and editing capacity is limited (only publishing 40 articles a year), we are forced to implement several policies regarding the restrictions on the types of articles that can be processed in the Borneo Journal of Pharmacy. These restrictions apply to:

1. Review Articles
We currently process many review articles, both narrative and systematic reviews (nearly 30% of the number of manuscripts processed). We apply a limit on the number of review articles in each issue of no more than 30% to accommodate original research articles, so we must limit the number of review articles that we can process. This limitation does not apply to manuscripts sent based on invitations to potential authors.

2. Articles with Molecular Docking Method
Currently, the Institute for Research and Community Services Universitas Muhammadiyah Palangkaraya publishes a journal that explicitly publishes various articles using the molecular docking method as the primary method: Journal of Molecular Docking (http://journal.umpalangkaraya.ac.id/index.php/jmd). Considering the high traffic of articles in the Borneo Journal of Pharmacy, including those that publish articles on molecular docking, we are temporarily not accepting articles of this type. We will advise authors to move their submissions to the Journal of Molecular Docking. This limitation does not apply to manuscripts that use molecular docking as a complementary method and not the primary analysis method.

The restrictions on these two types of manuscripts will be in place for 2022 and re-evaluated at the end of 2022. Once again, we thank all authors and prospective authors from the Borneo Journal of Pharmacy.
Borneo Journal of Pharmacy

Read more about Notification of limitations on publishing review articles and articles using the molecular docking method

Current Issue

Vol 5 No 3 (2022): Borneo Journal of Pharmacy

The publication of the Borneo Journal of Pharmacy positively participates in disseminating research and review of science and technology development conducted by lecturers and researchers, primarily from Universitas Muhammadiyah Palangkaraya and other universities. This edition contains ten articles: Pharmacognosy-Phytochemistry, Pharmaceutical, Microbiology Pharmacy, Natural Product Development, Clinical-Community Pharmacy, and Management Pharmacy. This edition includes writings from four countries: Costa Rica, Indonesia, Netherlands, and Nigeria. The authors come from several institutions, including Universitas Ahmad Dahlan, K24 Indonesia, Institut Sains dan Teknologi Nasional, Universidad de Costa Rica, Kebbi State University of Science and Technology, Aliero, Federal University, Birnin Kebbi, Sekolah Tinggi Teknologi Industri dan Farmasi Bogor, IPB University, National Research and Innovation Agency Republic of Indonesia, Poltekkes Kemenkes Bandung, Sekolah Tinggi Ilmu Farmasi Riau, Universitas Islam Negeri Maulana Malik Ibrahim, Universitas Airlangga, Universitas Hang Tuah, Universitas Katolik Widya Mandira, University of Groningen, Universitas Gadjah Mada, Universitas Hasanuddin, Universitas Syiah Kuala, Poltekkes Kemenkes Maluku, and Universitas Islam Sultan Agung.

Published: 2022-08-31

Natural Product Development


Clinical-Community Pharmacy

View All Issues